Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Olprinone Hydrochloride Injection

Approval Number

国药准字H20223940

Company湖南恒生制药股份有限公司

Registration Date

December 30, 2022

Drug Information

Generic Name

盐酸奥普力农注射液

Dosage Form

注射剂

Strength

5ml:5mg

Drug Type

化学药品

Registration Date

December 30, 2022

Company Information

Applicant Company

Company Name湖南恒生制药股份有限公司

Company Address

湖南省衡阳西渡经济技术开发区恒生路

Manufacturing Company

Company Name湖南恒生制药股份有限公司

Company Address

湖南省衡阳西渡经济技术开发区恒生路

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy